Bisphosphonate (BisP) Use May Be a Risk Factor for Osteonecrosis (ON) in Those Who Have Not Used Glucocorticoids (GCs): Data from the Health Improvement Network (THIN)

Oct-10

AUTHORS : Dr Yuqing Zhang (Details for study: Boston University School of Medicine), Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA – Email: yzhang108@mgh.harvard.edu – Profile: https://advances.massgeneral.org/contributors/contributor.aspx?id=1566

JOURNAL : Arthritis & Rheumatology

REFERENCE: 62(S10):S929-S930

DOI : 10.1002/art.30166

Bisphosphonate (BisP) Use May Be a Risk Factor for Osteonecrosis (ON) in Those Who Have Not Used Glucocorticoids (GCs): Data from the Health Improvement Network (THIN)

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study